Credo Technology Group Holding Ltd Work in process decreased by 10.7% to $23.59M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 36.3%, from $17.31M to $23.59M. Over 3 years (FY 2022 to FY 2025), Work in process shows an upward trend with a 33.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q1 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.35M | $10.34M | $7.20M | $6.32M | $8.26M | $7.47M | $9.56M | $12.31M | $17.31M | $24.58M | $28.75M | $26.42M | $23.59M |
| QoQ Change | — | -0.1% | -30.3% | -12.2% | +30.7% | -9.6% | +28.0% | +28.7% | +40.6% | +42.0% | +16.9% | -8.1% | -10.7% |
| YoY Change | — | — | -30.4% | — | -20.1% | +3.8% | +51.3% | — | +109.4% | +229.1% | +200.7% | +114.7% | +36.3% |
| % of Inventories | 37.9% | 20.5% | 15.6% | 15.5% | 26.2% | 28.8% | 30.3% | 33.9% | 32.5% | 27.3% | 24.6% | 17.6% | 11.3% |
| Share Change | — | -17.3pp | -4.9pp | -0.1pp | +10.7pp | +2.6pp | +1.5pp | +3.6pp | -1.4pp | -5.2pp | -2.7pp | -7.0pp | -6.2pp |